CORTEX PHARMACEUTIC Probability of Future Stock Price Finishing Under 3.5
| PHXDelisted Stock | USD 4.35 0.00 0.00% |
CORTEX |
CORTEX PHARMACEUTIC Target Price Odds to finish below 3.5
The tendency of CORTEX Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 3.50 or more in 90 days |
| 4.35 | 90 days | 3.50 | under 4 |
Based on a normal probability distribution, the odds of CORTEX PHARMACEUTIC to drop to $ 3.50 or more in 90 days from now is under 4 (This CORTEX PHARMACEUTIC probability density function shows the probability of CORTEX Stock to fall within a particular range of prices over 90 days) . Probability of CORTEX PHARMACEUTIC price to stay between $ 3.50 and its current price of $4.35 at the end of the 90-day period is about 81.82 .
Considering the 90-day investment horizon CORTEX PHARMACEUTIC has a beta of -0.17 indicating as returns on the benchmark increase, returns on holding CORTEX PHARMACEUTIC are expected to decrease at a much lower rate. During a bear market, however, CORTEX PHARMACEUTIC is likely to outperform the market. Additionally CORTEX PHARMACEUTIC has an alpha of 0.1797, implying that it can generate a 0.18 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). CORTEX PHARMACEUTIC Price Density |
| Price |
Predictive Modules for CORTEX PHARMACEUTIC
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CORTEX PHARMACEUTIC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.CORTEX PHARMACEUTIC Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CORTEX PHARMACEUTIC is not an exception. The market had few large corrections towards the CORTEX PHARMACEUTIC's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CORTEX PHARMACEUTIC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CORTEX PHARMACEUTIC within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.18 | |
β | Beta against Dow Jones | -0.17 | |
σ | Overall volatility | 0.30 | |
Ir | Information ratio | -0.02 |
CORTEX PHARMACEUTIC Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CORTEX PHARMACEUTIC for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CORTEX PHARMACEUTIC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CORTEX PHARMACEUTIC is not yet fully synchronised with the market data | |
| CORTEX PHARMACEUTIC had very high historical volatility over the last 90 days | |
| CORTEX PHARMACEUTIC has a very high chance of going through financial distress in the upcoming years | |
| About 69.0% of the company shares are owned by institutional investors | |
| On 4th of June 2025 CORTEX PHARMACEUTIC paid $ 0.04 per share dividend to its current shareholders | |
| Latest headline from fxstreet.com: WTI Oil hits fresh multi-week highs above 68.00 amid looming sanctions on Russia |
CORTEX PHARMACEUTIC Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CORTEX Stock often depends not only on the future outlook of the current and potential CORTEX PHARMACEUTIC's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CORTEX PHARMACEUTIC's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 37.5 M | |
| Cash And Short Term Investments | 2.2 M |
CORTEX PHARMACEUTIC Technical Analysis
CORTEX PHARMACEUTIC's future price can be derived by breaking down and analyzing its technical indicators over time. CORTEX Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of CORTEX PHARMACEUTIC. In general, you should focus on analyzing CORTEX Stock price patterns and their correlations with different microeconomic environments and drivers.
CORTEX PHARMACEUTIC Predictive Forecast Models
CORTEX PHARMACEUTIC's time-series forecasting models is one of many CORTEX PHARMACEUTIC's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary CORTEX PHARMACEUTIC's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about CORTEX PHARMACEUTIC
Checking the ongoing alerts about CORTEX PHARMACEUTIC for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for CORTEX PHARMACEUTIC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| CORTEX PHARMACEUTIC is not yet fully synchronised with the market data | |
| CORTEX PHARMACEUTIC had very high historical volatility over the last 90 days | |
| CORTEX PHARMACEUTIC has a very high chance of going through financial distress in the upcoming years | |
| About 69.0% of the company shares are owned by institutional investors | |
| On 4th of June 2025 CORTEX PHARMACEUTIC paid $ 0.04 per share dividend to its current shareholders | |
| Latest headline from fxstreet.com: WTI Oil hits fresh multi-week highs above 68.00 amid looming sanctions on Russia |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in CORTEX Stock
If you are still planning to invest in CORTEX PHARMACEUTIC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CORTEX PHARMACEUTIC's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Directory Find actively traded commodities issued by global exchanges |